CGEM vs ZYME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 12, 2026

CGEM

38.5
AI Score
VS
ZYME Wins

ZYME

39.1
AI Score

Investment Advisor Scores

CGEM

39score
Recommendation
SELL

ZYME

39score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric CGEM ZYME Winner
Forward P/E 6.7385 67.1141 CGEM
PEG Ratio 0 0 Tie
Revenue Growth 0.0% -90.6% CGEM
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 38.5/100 39.1/100 ZYME
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

CGEM 1M: +25.5% · 3M: +55.1% ZYME 1M: +24.0% · 3M: +14.2%

Current Technical Phase

CGEM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.2% over 20 days), RSI 68

RSI (14): 68.4 · Price: $21.68

ZYME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 72

RSI (14): 71.6 · Price: $28.67

Fundamentals Snapshot

Metric CGEM ZYME
Market Cap
Forward P/E -8.0 24.4
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -0.9%
Gross Margin -2.5%
Operating Margin 0.0% -9.2%
EPS -3.11 -2.02
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ZYME is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.